Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
The prevalence of antibodies against human T-cell lymphotrophic virus (HTLV-I/II) in blood donors from the city of Monterrey, Mexico was investigated. We found that 4 out of 1017 sera (0.39%) reacted against HTLV-I/II, as determined by a passive agglutination test (PA). However, none of PA-positive sera reacted to HTLV-I/II specific polypeptides as demonstrated by Western blot. These findings indicate that the population of Monterrey has very low or no seroprevalence for HTLV-I/II.
Trejo-Avila
L M
LM
Departamento de Microbiología e Inmunología, UANL, Monterrey, México.
Fuentes-Pensamiento
R
R
Scorro Flores-Castañeda
M
M
Diaz-Mendoza
M L
ML
Zapata-Benavides
P
P
Tamez-Guerra
R S
RS
D000293:Adolescent; D000328:Adult; D001782:Blood Donors; D005260:Female; D015481:HTLV-I Antibodies / Q000097:blood*; D015490:HTLV-I Infections / Q000097:blood / Q000453:epidemiology*; D015482:HTLV-II Antibodies / Q000097:blood*; D015491:HTLV-II Infections / Q000097:blood / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008800:Mexico / Q000453:epidemiology; D008875:Middle Aged; D015995:Prevalence
D015481:HTLV-I Antibodies; D015482:HTLV-II Antibodies